DR. MARK KIRSCHBAUM

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Cyclacel Pharmaceuticals, Inc.

Filing Date Source Excerpt
2023-11-14 Dr. Mark Kirschbaum(2) Includes options to purchase 5,556 shares of Common Stock that are exercisable within 60 days of November 6, 2023.

Data sourced from SEC filings. Last updated: 2026-02-03